Literature DB >> 27672416

Application of Nail Polish During Topical Management of Onychomycosis: Are Data Available to Guide the Clinician About What to Tell Their Patients?

James Q Del Rosso1.   

Abstract

Topical antifungal management of toenail onychomycosis has been fraught with several therapeutic challenges including difficulty gaining access to the site of infection and the need for prolonged durations of therapy. In addition, there has been a marked lack of information on the impact of toenail polish application on drug penetration after application. This article reviews available data from studies evaluating the effect of nail polish on antifungal drag penetration using ex vivo laboratory models with cadaver fingernail plates with both tavaborole 5% solution and efinaconazole 10% solution. In addition, changes in nail polish appearance and color transfer to applicators are also discussed, with changes noted with topical efinaconazole. Importantly, there are no data on whether or not nail polish application alters the efficacy of these topical agents.

Entities:  

Year:  2016        PMID: 27672416      PMCID: PMC5022994     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  9 in total

1.  In Vitro Nail Penetration of Tavaborole Topical Solution, 5%, Through Nail Polish on Ex Vivo Human Fingernails.

Authors:  Tracey Vlahovic; Tejal Merchant MPharm; Sanjay Chanda; Lee T Zane; Dina Coronado
Journal:  J Drugs Dermatol       Date:  2015-07       Impact factor: 2.114

2.  Onchomycosis: an overview.

Authors:  Boni E Elewski; Phoebe Rich; Antonella Tosti; David M Pariser; Richard Scher; Ralph C Daniel; Aditya K Gupta
Journal:  J Drugs Dermatol       Date:  2013-07-01       Impact factor: 2.114

3.  Penetration of ((14)C)-Efinaconazole Topical Solution, 10%, Does Not Appear to be Influenced by Nail Polish.

Authors:  Joshua A Zeichner; Linda Stein Gold; Andrew Korotzer
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

Review 4.  Onychomycosis: diagnosis and definition of cure.

Authors:  Richard K Scher; Amir Tavakkol; Bárdur Sigurgeirsson; Roderick J Hay; Warren S Joseph; Antonella Tosti; Philip Fleckman; Mahmoud Ghannoum; David G Armstrong; Bryan C Markinson; Boni E Elewski
Journal:  J Am Acad Dermatol       Date:  2007-02-16       Impact factor: 11.527

5.  Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.

Authors:  Boni E Elewski; Raza Aly; Sheryl L Baldwin; Remigio F González Soto; Phoebe Rich; Max Weisfeld; Hector Wiltz; Lee T Zane; Richard Pollak
Journal:  J Am Acad Dermatol       Date:  2015-05-05       Impact factor: 11.527

6.  Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.

Authors:  Misao Sakamoto; Noriaki Sugimoto; Hideki Kawabata; Eiko Yamakawa; Nobuyuki Kodera; Radhakrishnan Pillai; Yoshiyuki Tatsumi
Journal:  J Drugs Dermatol       Date:  2014-11       Impact factor: 2.114

7.  Evaluation of the Appearance of Nail Polish Following Daily Treatment of Ex Vivo Human Fingernails With Topical Solutions of Tavaborole or Efinaconazole.

Authors:  Tracey C Vlahovic; Dina Coronado; Sanjay Chanda; Tejal Merchant; Lee T Zane
Journal:  J Drugs Dermatol       Date:  2016-01       Impact factor: 2.114

8.  An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site.

Authors:  Fernando L Rock; Weimin Mao; Anya Yaremchuk; Mikhail Tukalo; Thibaut Crépin; Huchen Zhou; Yong-Kang Zhang; Vincent Hernandez; Tsutomu Akama; Stephen J Baker; Jacob J Plattner; Lucy Shapiro; Susan A Martinis; Stephen J Benkovic; Stephen Cusack; M R K Alley
Journal:  Science       Date:  2007-06-22       Impact factor: 47.728

9.  Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.

Authors:  Boni E Elewski; Phoebe Rich; Richard Pollak; David M Pariser; Shinichi Watanabe; Hisato Senda; Chikara Ieda; Kathleen Smith; Radhakrishnan Pillai; Tage Ramakrishna; Jason T Olin
Journal:  J Am Acad Dermatol       Date:  2012-11-20       Impact factor: 11.527

  9 in total
  1 in total

1.  Ciclopirox Hydroxypropyl Chitosan (CPX-HPCH) Nail Lacquer and Breathable Cosmetic Nail Polish: In Vitro Evaluation of Drug Transungual Permeation Following the Combined Application.

Authors:  Daniela Monti; Silvia Tampucci; Valentina Paganini; Susi Burgalassi; Patrizia Chetoni; Jordi Galván; Francesco Celandroni; Emilia Ghelardi
Journal:  Life (Basel)       Date:  2022-05-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.